Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amphetamine, but not methylphenidate, predicts antidepressant efficacy.

K Y Little1

  • 1Department of Psychiatry, University of Kentucky Medical Center, Lexington 40536-0080.

Journal of Clinical Psychopharmacology
|June 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Striatal dopaminergic abnormalities in human cocaine users.

The American journal of psychiatry·1999
Same author

Overt behavior problems and serotonergic function in middle childhood among male and female offspring of alcoholic fathers.

Alcoholism, clinical and experimental research·1998
Same author

Brain dopamine transporter messenger RNA and binding sites in cocaine users: a postmortem study.

Archives of general psychiatry·1998
Same author

Expression and regulation of the human dopamine transporter in a neuronal cell line.

Brain research. Molecular brain research·1998
Same author

GABA(A) receptor alpha1, alpha4, and beta3 subunit mRNA and protein expression in the frontal cortex of human alcoholics.

Alcoholism, clinical and experimental research·1998
Same author

A.E. Bennett Research Award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression.

Biological psychiatry·1998

Acute stimulant response may predict antidepressant improvement. Amphetamine responders showed higher improvement rates than nonresponders, unlike methylphenidate responders, suggesting amphetamine sensitivity predicts treatment outcomes.

Area of Science:

  • Psychopharmacology
  • Neuroscience
  • Clinical Psychiatry

Background:

  • Investigating predictors of antidepressant treatment response is crucial for personalized medicine.
  • Acute stimulant response has been explored as a potential biomarker for antidepressant efficacy.

Purpose of the Study:

  • To analyze the relationship between acute stimulant response and subsequent improvement with antidepressant treatment.
  • To compare the predictive value of amphetamine and methylphenidate response on antidepressant outcomes.

Main Methods:

  • Systematic review of five studies examining stimulant challenge tests and antidepressant treatment response.
  • Analysis of differential improvement rates between stimulant responders and nonresponders.

Main Results:

Related Experiment Videos

  • Amphetamine responders demonstrated an 85% improvement rate with antidepressants, versus 43% for nonresponders.
  • Methylphenidate responders and nonresponders showed equivalent antidepressant improvement rates.
  • Amphetamine sensitivity may be an independent trait predicting tricyclic antidepressant responsiveness.

Conclusions:

  • Acute amphetamine response, unlike methylphenidate response, appears predictive of antidepressant treatment success.
  • Amphetamine sensitivity may represent a pharmacodynamic trait relevant to antidepressant efficacy.
  • Further research is needed to clarify optimal amphetamine challenge protocols and clinical applications.